Back to Search Start Over

Poor hydroxylator phenotypes of debrisoquine and S-mephenytoin are not over-represented in a group of patients with Parkinson's disease.

Authors :
Gudjonsson O
Sanz E
Alván G
Aquilonius SM
Reviriego J
Source :
British journal of clinical pharmacology [Br J Clin Pharmacol] 1990 Aug; Vol. 30 (2), pp. 301-2.
Publication Year :
1990

Details

Language :
English
ISSN :
0306-5251
Volume :
30
Issue :
2
Database :
MEDLINE
Journal :
British journal of clinical pharmacology
Publication Type :
Editorial & Opinion
Accession number :
2206793
Full Text :
https://doi.org/10.1111/j.1365-2125.1990.tb03780.x